{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:10:22Z","timestamp":1792696222673,"version":"4.5.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,27]],"date-time":"2021-09-27T00:00:00Z","timestamp":1632700800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,27]],"date-time":"2021-09-27T00:00:00Z","timestamp":1632700800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["K23DK124515"],"award-info":[{"award-number":["K23DK124515"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["K24DK106414"],"award-info":[{"award-number":["K24DK106414"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R21HL133694"],"award-info":[{"award-number":["R21HL133694"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Peripheral neuropathy is associated with substantial morbidity, but risk factors other than diabetes are largely uncharacterized. The aim of this study was to describe the prevalence and risk factors for peripheral neuropathy in adults with and without diabetes from two different population-based studies in the US. We performed a cross-sectional analysis of 5200 black and white participants from NHANES (1999\u20132004, age 40\u201385\u00a0years) and 3362 black and white participants from the ARIC Study (2016\u20132017, age 70\u201389\u00a0years) who underwent monofilament testing for peripheral neuropathy using a shared protocol. We used logistic regression to quantify age, sex, and race-adjusted risk factor associations for peripheral neuropathy among middle-aged (40\u201369\u00a0years) and older (\u2265\u200970\u00a0years) adults. The age, sex, and race-adjusted prevalence of peripheral neuropathy (decreased sensation on monofilament testing) was 10.4% for middle-aged adults in NHANES, 26.8% for older adults in NHANES, and 39.2% for older adults in ARIC. Diabetes was an important risk factor, but more strongly associated with peripheral neuropathy in middle-aged (OR\u2009~\u20095 for long-standing diabetes) compared to older adults (ORs\u2009~\u20091.5\u20132). Male sex (ORs\u2009~\u20092), black race (ORs\u2009~\u20091.3\u20131.5), and greater height (ORs\u2009~\u20091.5\u20133) were robust risk factors for peripheral neuropathy. Other risk factors included body mass index, education, and peripheral artery disease. The burden of peripheral neuropathy defined by abnormal monofilament testing among older adults is substantial, even among adults without diabetes. Studies are needed to understand the etiology and prognosis of peripheral neuropathy in the absence of diabetes.<\/jats:p>","DOI":"10.1038\/s41598-021-98565-w","type":"journal-article","created":{"date-parts":[[2021,9,27]],"date-time":"2021-09-27T10:20:00Z","timestamp":1632738000000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":86,"title":["Prevalence of peripheral neuropathy defined by monofilament insensitivity in middle-aged and older adults in two US cohorts"],"prefix":"10.1038","volume":"11","author":[{"given":"Caitlin W.","family":"Hicks","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. Gwen","family":"Windham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunihiro","family":"Matsushita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Selvin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,27]]},"reference":[{"key":"98565_CR1","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/j.mayocp.2015.05.004","volume":"90","author":"JC Watson","year":"2015","unstructured":"Watson, J. C. & Dyck, P. J. Peripheral neuropathy: A practical approach to diagnosis and symptom management. Mayo Clin. Proc. 90, 940\u2013951 (2015).","journal-title":"Mayo Clin. Proc."},{"key":"98565_CR2","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1007\/s11892-014-0528-7","volume":"14","author":"L Ang","year":"2014","unstructured":"Ang, L., Jaiswal, M., Martin, C. & Pop-Busui, R. Glucose control and diabetic neuropathy: Lessons from recent large clinical trials. Curr. Diabetes Rep. 14, 528 (2014).","journal-title":"Curr. Diabetes Rep."},{"key":"98565_CR3","doi-asserted-by":"publisher","first-page":"956","DOI":"10.2337\/diacare.28.4.956","volume":"28","author":"AJ Boulton","year":"2005","unstructured":"Boulton, A. J. et al. Diabetic neuropathies: A statement by the American Diabetes Association. Diabetes Care 28, 956\u2013962 (2005).","journal-title":"Diabetes Care"},{"key":"98565_CR4","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.clinthera.2018.04.001","volume":"40","author":"Z Iqbal","year":"2018","unstructured":"Iqbal, Z. et al. Diabetic peripheral neuropathy: Epidemiology, diagnosis, and pharmacotherapy. Clin. Ther. 40, 828\u2013849 (2018).","journal-title":"Clin. Ther."},{"key":"98565_CR5","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1007\/BF00400697","volume":"36","author":"MJ Young","year":"1993","unstructured":"Young, M. J., Boulton, A. J., MacLeod, A. F., Williams, D. R. & Sonksen, P. H. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia 36, 150\u2013154 (1993).","journal-title":"Diabetologia"},{"key":"98565_CR6","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1212\/WNL.45.6.1115","volume":"45","author":"PJ Dyck","year":"1995","unstructured":"Dyck, P. J. et al. Variables influencing neuropathic endpoints: The Rochester Diabetic Neuropathy Study of Healthy Subjects. Neurology 45, 1115\u20131121 (1995).","journal-title":"Neurology"},{"key":"98565_CR7","doi-asserted-by":"publisher","first-page":"2378","DOI":"10.2337\/diacare.28.10.2378","volume":"28","author":"L Vileikyte","year":"2005","unstructured":"Vileikyte, L. et al. Diabetic peripheral neuropathy and depressive symptoms: The association revisited. Diabetes Care 28, 2378\u20132383 (2005).","journal-title":"Diabetes Care"},{"key":"98565_CR8","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1159\/000022017","volume":"44","author":"K Koski","year":"1998","unstructured":"Koski, K., Luukinen, H., Laippala, P. & Kivela, S. L. Risk factors for major injurious falls among the home-dwelling elderly by functional abilities A prospective population-based study. Gerontology 44, 232\u2013238 (1998).","journal-title":"Gerontology"},{"key":"98565_CR9","doi-asserted-by":"publisher","first-page":"167","DOI":"10.7326\/M20-1340","volume":"174","author":"CW Hicks","year":"2021","unstructured":"Hicks, C. W., Wang, D., Matsushita, K., Windham, B. G. & Selvin, E. Peripheral neuropathy and all-cause and cardiovascular mortality in U.S. adults: A prospective cohort study. Ann. Intern. Med. 174, 167\u2013174 (2021).","journal-title":"Ann. Intern. Med."},{"key":"98565_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0242406","volume":"15","author":"S Doshi","year":"2020","unstructured":"Doshi, S. et al. Chronic kidney disease as a risk factor for peripheral nerve impairment in older adults: A longitudinal analysis of Health, Aging and Body Composition (Health ABC) study. PLoS\u00a0One 15, e0242406 (2020).","journal-title":"PLoS\u00a0One"},{"key":"98565_CR11","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.annepidem.2019.07.012","volume":"37","author":"JR Dusendang","year":"2019","unstructured":"Dusendang, J. R. et al. The association between perceived discrimination in midlife and peripheral neuropathy in a population-based cohort of women: The Study of Women\u2019s Health Across the Nation. Ann. Epidemiol. 37, 10\u201316 (2019).","journal-title":"Ann. Epidemiol."},{"key":"98565_CR12","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1123\/japa.2015-0207","volume":"24","author":"BS Lange-Maia","year":"2016","unstructured":"Lange-Maia, B. S. et al. Sensorimotor peripheral nerve function and physical activity in older men. J. Aging Phys. Act. 24, 559\u2013566 (2016).","journal-title":"J. Aging Phys. Act."},{"key":"98565_CR13","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1007\/s00125-020-05194-5","volume":"63","author":"J van der Velde","year":"2020","unstructured":"van der Velde, J. et al. Cardiometabolic risk factors as determinants of peripheral nerve function: The Maastricht Study. Diabetologia 63, 1648\u20131658 (2020).","journal-title":"Diabetologia"},{"key":"98565_CR14","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.apmr.2013.11.018","volume":"95","author":"RE Ward","year":"2014","unstructured":"Ward, R. E. et al. Peripheral nerve function and lower extremity muscle power in older men. Arch. Phys. Med. Rehabil. 95, 726\u2013733 (2014).","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"98565_CR15","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1093\/aje\/kws327","volume":"177","author":"KR Ylitalo","year":"2013","unstructured":"Ylitalo, K. R., Herman, W. H. & Harlow, S. D. Performance-based physical functioning and peripheral neuropathy in a population-based cohort of women at midlife. Am. J. Epidemiol. 177, 810\u2013817 (2013).","journal-title":"Am. J. Epidemiol."},{"key":"98565_CR16","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.diabres.2007.01.005","volume":"77","author":"EW Gregg","year":"2007","unstructured":"Gregg, E. W. et al. Prevalence of lower extremity diseases associated with normal glucose levels, impaired fasting glucose, and diabetes among U.S. adults aged 40 or older. Diabetes Res. Clin. Pract. 77, 485\u2013488 (2007).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"98565_CR17","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.2337\/dc12-1102","volume":"36","author":"JG Katon","year":"2013","unstructured":"Katon, J. G., Reiber, G. E. & Nelson, K. M. Peripheral neuropathy defined by monofilament insensitivity and diabetes status: NHANES 1999\u20132004. Diabetes Care 36, 1604\u20131606 (2013).","journal-title":"Diabetes Care"},{"key":"98565_CR18","doi-asserted-by":"publisher","first-page":"S124","DOI":"10.2337\/dc19-S011","volume":"42","author":"American Diabetes Association","year":"2019","unstructured":"American Diabetes Association. 11. Microvascular complications and foot care: Standards of Medical Care in Diabetes-2019. Diabetes Care 42, S124\u2013S138 (2019).","journal-title":"Diabetes Care"},{"key":"98565_CR19","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.2337\/dc08-9021","volume":"31","author":"AJ Boulton","year":"2008","unstructured":"Boulton, A. J. et al. Comprehensive foot examination and risk assessment: A report of the task force of the foot care interest group of the American Diabetes Association, with endorsement by the American Association of Clinical Endocrinologists. Diabetes Care 31, 1679\u20131685 (2008).","journal-title":"Diabetes Care"},{"key":"98565_CR20","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1001\/archinte.158.3.289","volume":"158","author":"DG Armstrong","year":"1998","unstructured":"Armstrong, D. G., Lavery, L. A., Vela, S. A., Quebedeaux, T. L. & Fleischli, J. G. Choosing a practical screening instrument to identify patients at risk for diabetic foot ulceration. Arch. Intern. Med. 158, 289\u2013292 (1998).","journal-title":"Arch. Intern. Med."},{"key":"98565_CR21","unstructured":"Services CfMM. Decision Memo for Diabetic Peripheral Neuropathy with Loss of Protective Sensation (LOPS) (CAG-00059N) (2001)."},{"key":"98565_CR22","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1007\/s001250051063","volume":"41","author":"J Cabezas-Cerrato","year":"1998","unstructured":"Cabezas-Cerrato, J. The prevalence of clinical diabetic polyneuropathy in Spain: A study in primary care and hospital clinic groups. Neuropathy Spanish Study Group of the Spanish Diabetes Society (SDS). Diabetologia 41, 1263\u20131269 (1998).","journal-title":"Diabetologia"},{"key":"98565_CR23","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1056\/NEJMoa032782","volume":"352","author":"S Tesfaye","year":"2005","unstructured":"Tesfaye, S. et al. Vascular risk factors and diabetic neuropathy. N. Engl. J. Med. 352, 341\u2013350 (2005).","journal-title":"N. Engl. J. Med."},{"key":"98565_CR24","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.2337\/db08-1771","volume":"58","author":"TD Wiggin","year":"2009","unstructured":"Wiggin, T. D. et al. Elevated triglycerides correlate with progression of diabetic neuropathy. Diabetes 58, 1634\u20131640 (2009).","journal-title":"Diabetes"},{"key":"98565_CR25","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s11596-017-1737-5","volume":"37","author":"Y Unmar","year":"2017","unstructured":"Unmar, Y., Zafar, M. I. & Gao, F. Factors associated with peripheral neuropathy in type 2 diabetes: Subclinical versus confirmed neuropathy. J. Huazhong Univ. Sci. Technol. Med. Sci. 37, 337\u2013342 (2017).","journal-title":"J. Huazhong Univ. Sci. Technol. Med. Sci."},{"key":"98565_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.diabres.2019.03.029","volume":"151","author":"MT Olaiya","year":"2019","unstructured":"Olaiya, M. T. et al. Use of graded Semmes Weinstein monofilament testing for ascertaining peripheral neuropathy in people with and without diabetes. Diabetes Res. Clin. Pract. 151, 1\u201310 (2019).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"98565_CR27","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1007\/s11606-015-3354-y","volume":"30","author":"C Clair","year":"2015","unstructured":"Clair, C., Cohen, M. J., Eichler, F., Selby, K. J. & Rigotti, N. A. The effect of cigarette smoking on diabetic peripheral neuropathy: A systematic review and meta-analysis. J. Gen. Intern. Med. 30, 1193\u20131203 (2015).","journal-title":"J. Gen. Intern. Med."},{"key":"98565_CR28","doi-asserted-by":"publisher","first-page":"517","DOI":"10.2337\/dc07-1755","volume":"31","author":"EG Gerrits","year":"2008","unstructured":"Gerrits, E. G. et al. Skin autofluorescence: A tool to identify type 2 diabetic patients at risk for developing microvascular complications. Diabetes Care 31, 517\u2013521 (2008).","journal-title":"Diabetes Care"},{"key":"98565_CR29","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.2337\/diacare.20.7.1162","volume":"20","author":"AI Adler","year":"1997","unstructured":"Adler, A. I. et al. Risk factors for diabetic peripheral sensory neuropathy. Results of the Seattle Prospective Diabetic Foot Study. Diabetes Care 20, 1162\u20131167 (1997).","journal-title":"Diabetes Care"},{"key":"98565_CR30","first-page":"120","volume":"14","author":"DB Karki","year":"2016","unstructured":"Karki, D. B. et al. Prevalence of sensory neuropathy in type 2 diabetes mellitus and its correlation with duration of disease. Kathmandu Univ. Med. J. (KUMJ) 14, 120\u2013124 (2016).","journal-title":"Kathmandu Univ. Med. J. (KUMJ)"},{"key":"98565_CR31","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1212\/WNL.0b013e318227b227","volume":"77","author":"S Debette","year":"2011","unstructured":"Debette, S. et al. Midlife vascular risk factor exposure accelerates structural brain aging and cognitive decline. Neurology 77, 461\u2013468 (2011).","journal-title":"Neurology"},{"key":"98565_CR32","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.005608","author":"MC Power","year":"2017","unstructured":"Power, M. C. et al. Midlife and late-life vascular risk factors and white matter microstructural integrity: The atherosclerosis risk in communities neurocognitive study. J. Am. Heart Assoc. https:\/\/doi.org\/10.1161\/JAHA.117.005608 (2017).","journal-title":"J. Am. Heart Assoc."},{"key":"98565_CR33","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1001\/jamaneurol.2017.1658","volume":"74","author":"RF Gottesman","year":"2017","unstructured":"Gottesman, R. F. et al. Associations between midlife vascular risk factors and 25-year incident dementia in the Atherosclerosis Risk in Communities (ARIC) cohort. JAMA Neurol. 74, 1246\u20131254 (2017).","journal-title":"JAMA Neurol."},{"key":"98565_CR34","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1002\/acn3.50936","volume":"6","author":"SC Conner","year":"2019","unstructured":"Conner, S. C. et al. Mid-life and late-life vascular risk factor burden and neuropathology in old age. Ann. Clin. Transl. Neurol. 6, 2403\u20132412 (2019).","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"98565_CR35","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1093\/aje\/kwz210","volume":"188","author":"NM Armstrong","year":"2019","unstructured":"Armstrong, N. M., Bangen, K. J., Au, R. & Gross, A. L. Associations between midlife (but not late-life) elevated coronary heart disease risk and lower cognitive performance: Results from the Framingham offspring study. Am. J. Epidemiol. 188, 2175\u20132187 (2019).","journal-title":"Am. J. Epidemiol."},{"key":"98565_CR36","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1093\/clinchem\/hvaa051","volume":"66","author":"CW Hicks","year":"2020","unstructured":"Hicks, C. W. et al. Associations of cardiac, kidney, and diabetes biomarkers with peripheral neuropathy among older adults in the Atherosclerosis Risk in Communities (ARIC) study. Clin. Chem. 66, 686\u2013696 (2020).","journal-title":"Clin. Chem."},{"key":"98565_CR37","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1016\/j.neuron.2017.02.005","volume":"93","author":"EL Feldman","year":"2017","unstructured":"Feldman, E. L., Nave, K. A., Jensen, T. S. & Bennett, D. L. H. New horizons in diabetic neuropathy: Mechanisms, bioenergetics, and pain. Neuron 93, 1296\u20131313 (2017).","journal-title":"Neuron"},{"key":"98565_CR38","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1136\/jnnp.62.4.310","volume":"62","author":"CN Martyn","year":"1997","unstructured":"Martyn, C. N. & Hughes, R. A. Epidemiology of peripheral neuropathy. J. Neurol. Neurosurg. Psychiatry 62, 310\u2013318 (1997).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"98565_CR39","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1097\/WCO.0000000000000726","volume":"32","author":"MP Lunn","year":"2019","unstructured":"Lunn, M. P. Neuropathies and paraproteins. Curr. Opin. Neurol. 32, 658\u2013665 (2019).","journal-title":"Curr. Opin. Neurol."},{"key":"98565_CR40","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/B978-0-444-52902-2.00041-2","volume":"115","author":"H Koike","year":"2013","unstructured":"Koike, H. & Sobue, G. Paraneoplastic neuropathy. Handb. Clin. Neurol. 115, 713\u2013726 (2013).","journal-title":"Handb. Clin. Neurol."},{"key":"98565_CR41","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1111\/j.1365-2125.2011.04111.x","volume":"73","author":"K Chopra","year":"2012","unstructured":"Chopra, K. & Tiwari, V. Alcoholic neuropathy: Possible mechanisms and future treatment possibilities. Br. J. Clin. Pharmacol. 73, 348\u2013362 (2012).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"98565_CR42","doi-asserted-by":"publisher","first-page":"569","DOI":"10.7326\/M14-1650","volume":"163","author":"Y Gepner","year":"2015","unstructured":"Gepner, Y. et al. Effects of initiating moderate alcohol intake on cardiometabolic risk in adults with type 2 diabetes: A 2-year randomized, controlled trial. Ann. Intern. Med. 163, 569\u2013579 (2015).","journal-title":"Ann. Intern. Med."},{"key":"98565_CR43","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.2337\/dc14-1982","volume":"38","author":"SJ Brown","year":"2015","unstructured":"Brown, S. J., Handsaker, J. C., Bowling, F. L., Boulton, A. J. & Reeves, N. D. Diabetic peripheral neuropathy compromises balance during daily activities. Diabetes Care 38, 1116\u20131122 (2015).","journal-title":"Diabetes Care"},{"key":"98565_CR44","doi-asserted-by":"publisher","first-page":"391","DOI":"10.2337\/dc07-1152","volume":"31","author":"AV Schwartz","year":"2008","unstructured":"Schwartz, A. V. et al. Diabetes-related complications, glycemic control, and falls in older adults. Diabetes Care 31, 391\u2013396 (2008).","journal-title":"Diabetes Care"},{"key":"98565_CR45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0154654","volume":"11","author":"B Timar","year":"2016","unstructured":"Timar, B. et al. The impact of diabetic neuropathy on balance and on the risk of falls in patients with type 2 diabetes mellitus: A cross-sectional study. PLoS\u00a0One 11, e0154654 (2016).","journal-title":"PLoS\u00a0One"},{"key":"98565_CR46","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.mcna.2013.03.008","volume":"97","author":"DJ Margolis","year":"2013","unstructured":"Margolis, D. J. & Jeffcoate, W. Epidemiology of foot ulceration and amputation: Can global variation be explained?. Med. Clin. North Am. 97, 791\u2013805 (2013).","journal-title":"Med. Clin. North Am."},{"key":"98565_CR47","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1111\/j.1464-5491.2012.03644.x","volume":"29","author":"WH Herman","year":"2012","unstructured":"Herman, W. H. et al. Use of the Michigan Neuropathy Screening Instrument as a measure of distal symmetrical peripheral neuropathy in Type 1 diabetes: Results from the Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications. Diabetes Med. 29, 937\u2013944 (2012).","journal-title":"Diabetes Med."},{"key":"98565_CR48","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.2337\/diacare.17.11.1281","volume":"17","author":"EL Feldman","year":"1994","unstructured":"Feldman, E. L. et al. A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care 17, 1281\u20131289 (1994).","journal-title":"Diabetes Care"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-98565-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-98565-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-98565-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T16:15:29Z","timestamp":1670084129000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-98565-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,27]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["98565"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-98565-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,27]]},"assertion":[{"value":"3 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19159"}}